Jornal de Biomarcadores Moleculares e Diagnóstico

Drug Utilization Evaluation (DUE) on Enoxaparin in Venous Thromboembolism (VTE) Prophylaxis for Hip and Knee Replacement Surgery

Abstract

Yue Ling Chung, Kai Xin Ng, and Kah Weng Lai

Aim: The study aims to assess the adequacy and appropriateness of the use of chemical prophylaxis/enoxaparin in total knee and/or hip replacement (TKR and THR) surgery patients at National University Hospital (NUH) with respect to the compliance/non-compliance to NUH Venous-Thromboembolism (VTE) Prophylaxis Guidelines. This is done with the objective to identify potential gaps in current prescribing patterns that may require interventions to improve clinical efficacy and safety outcomes.

Methodology: A retrospective drug utilization evaluation was performed for NUH patients aged≥18 years old who have undergone TKR and/or THR surgery from 1st January to 31st May 2013 and excluded foreigners not residing in Singapore. The study indicators included compliance of chemoprophylaxis/enoxaparin prescribing patterns to NUH guidelines. Efficacy and safety related clinical outcomes in terms of VTE and hemorrhagic events respectively in a 3-months follow-up period post-surgery were also measured.

Results: A total of 127 patients were available for evaluation but data for 82 patients were collected and analyzed. Chemoprophylaxis prescribing patterns for only 46 (56.1%) patients were compliant to NUH guidelines in terms of indication. The need for chemoprophylaxis exceeded bleeding risks for 55 (67.1%) patients but only 30 (36.6%) patients were given chemoprophylaxis (enoxaparin). When enoxaparin was prescribed, none of the dosing regimens were compliant to NUH guidelines in all aspects of dose and frequency, prophylaxis duration and time of first dose initiation. During the 3-months follow-up, no bleeding events due to enoxaparin occurred. 9 (11.0%) patients developed thrombosis, 2 of which considered as clinically significant by physicians.

Conclusion: The study revealed the baseline chemoprophylaxis and enoxaparin usage patterns in NUH TKR and THR patients. The adverse clinical outcomes that occurred identified potential safety gaps within the prescribing practices, for which recommendations were made to improve the safe and effective use of VTE chemoprophylaxis in NUH post-surgical orthopedic patients.